Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
11.58
+0.75 (6.93%)
At close: Jan 21, 2025, 4:00 PM
11.63
+0.05 (0.43%)
After-hours: Jan 21, 2025, 7:13 PM EST
Company Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States.
Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.
It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.
Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Ginkgo Bioworks Holdings, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,218 |
| CEO | Jason Kelly |
Contact Details
Address: 27 Drydock Avenue, 8th Floor Boston, Massachusetts 02210 United States | |
| Phone | 877 422 5362 |
| Website | ginkgobioworks.com |
Stock Details
| Ticker Symbol | DNA |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001830214 |
| CUSIP Number | 37611X100 |
| ISIN Number | US37611X1000 |
| Employer ID | 87-2652913 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jason Kelly Ph.D. | Founder, Chief Executive Officer and Director |
| Dr. Reshma P. Shetty | Founder, President, Chief Operating Officer and Director |
| Mark E. Dmytruk | Chief Financial Officer |
| Thomas Knight Jr. | Founder |
| Austin Che Ph.D. | Founder, Head of Strategy and Treasurer |
| Bartholomew Canton Ph.D. | Founder, Chief Technology Officer and Secretary |
| Steven P. Coen CPA | Chief Accounting Officer |
| Karen Tepichin | General Counsel and Secretary |
| Anna Marie Wagner M.B.A. | Senior Vice President of Corporate Development |
| Samantha Sutton | Head of People |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 21, 2025 | 144 | Filing |
| Jan 17, 2025 | 144 | Filing |
| Jan 16, 2025 | 144 | Filing |
| Jan 15, 2025 | 144 | Filing |
| Jan 14, 2025 | 144 | Filing |
| Jan 13, 2025 | 144 | Filing |
| Jan 10, 2025 | SCHEDULE 13G/A | Filing |
| Jan 10, 2025 | 144 | Filing |
| Jan 8, 2025 | 144 | Filing |
| Jan 7, 2025 | 144 | Filing |